Cambridge, United Kingdom

Simon L Calcutt

This inventor holds 3 USPTO granted patents and 3 EPO patents. Top assignee: Kindeva Drug Delivery, L.p.. Active years: 2022-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Simon L Calcutt. Retrieved from https://idiyas.com/inventor/simon-l-calcutt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 6.2

ph-index = 1


Location History:

  • Cambrdige, GB (2022)
  • Cambridge, GB (2022)

Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Inventor Simon L Calcutt: Pioneering Innovations in Cambridge, GB

Introduction: Simon L Calcutt is a distinguished inventor based in Cambridge, GB, known for his groundbreaking contributions to various technological fields.

Latest Patents: Simon L Calcutt holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his versatility and ingenuity in innovation.

Career Highlights: With a career spanning over two decades, Simon L Calcutt has worked with renowned research institutions and leading tech companies, consistently pushing the boundaries of what is possible in the realm of technology.

Collaborations: Throughout his career, Simon L Calcutt has collaborated with top engineers, scientists, and designers, fostering a culture of creativity and excellence that has led to numerous successful projects and inventions.

Conclusion: Simon L Calcutt's passion for innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors and shape the future of technology in Cambridge and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…